Description
This finding contradicts established literature showing TREM2 as neuroprotective in Alzheimer’s disease and other neurodegenerative conditions. The context-dependent role of TREM2 in different pathological states needs mechanistic clarification to guide therapeutic targeting.
Gap type: contradiction Source paper: Trem2 deficiency attenuates microglial phagocytosis and autophagic-lysosomal activation in white matter hypoperfusion. (None, None, PMID:37823326)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:24.187810+00:00”, “resolution_summary”: “Resolved by hypothesis h-f373e16bb108: EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia Silences Neuroprotective Gene Programs — Reversible by EZH2 Inhibitors. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-f373e16bb108”, “title”: “EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia Silences Neuroprotective Gene Programs — Reversible by EZH2 Inhibitors”, “score”: 0.261, “reason”: “13 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “EZH2 (PRC2) → H3K27me3 silencing of BDNF, GRN, TREM2, MerTK”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.7136330000000001, “confidence_score”: 0.28, “status”: “proposed”, “pubmed_evidence_ids”: [“31048495”, “31202798”, “32553389”, “32933418”]}, {“id”: “h-aa1f5de5cd”, “title”: “TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switching from protective ‘disease-associated microglia’ to neurotoxic ‘inflammasome-active’ states”, “score”: 0.25, “reason”: “22 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-02-gap-synaptic-pruning-microglia”, “target_gene”: “TREM2, TYROBP (DAP12), APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7, “confidence_score”: 0.22, “status”: “proposed”, “pubmed_evidence_ids”: [“26598730”, “27753624”, “28602351”, “28802038”, “29070674”]}, {“id”: “h-1eaa052225”, “title”: “Regional TREM2-Dependent Lipid Metabolism Determines Cortical Vulnerability in Alzheimer’s Disease”, “score”: 0.246, “reason”: “17 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041439-ec89b1e4”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.713763, “confidence_score”: 0.3, “status”: “proposed”, “pubmed_evidence_ids”: [“23529425”, “26763208”, “30664783”, “32302527”, “N/A”]}, {“id”: “h-48858e2a”, “title”: “Microglial TREM2-SYK Pathway Enhancement”, “score”: 0.24, “reason”: “21 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-03-gap-seaad-v4-20260402065846”, “target_gene”: “TREM2”, “target_pathway”: “TREM2/TYROBP microglial signaling”, “disease”: “neurodegeneration”, “composite_score”: 0.798, “confidence_score”: 0.7, “status”: “promoted”, “pubmed_evidence_ids”: [“35921534”, “36306735”, “37099634”, “38712251”, “39048816”]}, {“id”: “h-b9794c8e29”, “title”: “Microglial TREM2 Activation Reduces Amyloid-Associated Neurotoxicity”, “score”: 0.24, “reason”: “4 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-TEST-PREREG-003”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.71, “confidence_score”: 0.78, “status”: “proposed”, “pubmed_evidence_ids”: [“24121985”, “29548884”, “31253634”, “32109293”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “title”: “The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis.\n\nGap type: contradiction\nSource paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. (None, None, PMID:28612290)”, “score”: 0.563, “reason”: “12 token overlaps; entity overlap: pmid, trem2”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “quality_score”: 0.56, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-075356-20920528_20260416-034507”, “title”: “This finding contradicts the established paradigm that autophagy is generally protective in neurons and neurodegenerative diseases. The counterintuitive result that blocking autophagy reduces neuronal death challenges current therapeutic approaches targeting autophagy enhancement.\n\nGap type: contradiction\nSource paper: Autophagy fails to prevent glucose deprivation/glucose reintroduction-induced neuronal death due to calpain-mediated lysosomal dysfunction in cortical neurons. (2017, Cell death & disease, PMID:28661473)”, “score”: 0.425, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-075356-20920528”, “quality_score”: 0.74, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193701-11582758_20260416-035652”, “title”: “The abstract reveals contradictory evidence where clusterin is proposed as a protective chaperone protein, yet knockout studies show it exacerbates neuronal death in hypoxia-ischemia. This fundamental contradiction undermines therapeutic targeting strategies.\n\nGap type: contradiction\nSource paper: Clusterin. (None, None, PMID:11906815)”, “score”: 0.413, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193701-11582758”, “quality_score”: 0.72, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-150500-e110aab9_20260413-225442”, “title”: “This study identifies oligodendrocytes as drivers of neuroinflammation in PD, contradicting the established paradigm that microglia are the primary neuroinflammatory cells. Understanding this cell-type hierarchy is crucial for targeting the right therapeutic cells.\n\nGap type: contradiction\nSource paper: Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson’s disease via the prosaposin-GPR37-IL-6 axis. (2025, Cell Rep, PMID:39913287)”, “score”: 0.408, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-150500-e110aab9”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-174607-708e8d91”, “title”: “The finding that Mertk/Axl deficiency increases viral susceptibility contradicts the established paradigm that TAM receptors dampen antiviral immunity. This unexpected protective role challenges current understanding of TAM receptor function in neuroinvasive infections.\n\nGap type: contradiction\nSource paper: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. (2015, Nature medicine, PMID:26523970)”, “score”: 0.396, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-174607-708e8d91”, “quality_score”: 0.75, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}